Noninvasive occipital and trigeminal neuromodulation technology cleared by FDA for the acute treatment of migraine

American Headache Society :Device worn as headset delivers stimulation to six branches of the occipital and trigeminal nervesOn March 2, Neurolief announced that it has received Food and Drug Administration (FDA) clearance for its Relivion^® system, a non-invasive, multi-channel neuromodulation system for at home, acute treatment of migraine attacks. The device is worn as a headset and stimulates occipital and trigeminal nerves according to the company’s March 2 press release.

Headache: Don't just take an over-the-counter painkiller

Yale: The person in the airplane seat next to yours is wearing strong perfume and, minutes after takeoff, you get a headache. A week after a cold, your sinuses remain clogged and you get a headache. The barometric pressure drops as summer cools into fall, and pain jabs through your head again. Conventional wisdom holds that those are three different causes of three different headaches. But now researchers say those episodes were most likely going to happen anyway.